Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
United States
/
Healthcare
Create a narrative
Humana Community
NYSE:HUM Community
3
Narratives
written by author
0
Comments
on narratives written by author
97
Fair Values set
on narratives written by author
Community Investing Ideas
Humana
Popular
Undervalued
Overvalued
Humana
AN
AnalystLowTarget
Consensus Narrative from 22 Analysts
Reforms And Rising Costs Will Erode Medicare Margins
Key Takeaways Heavy reliance on Medicare Advantage exposes Humana to regulatory changes, political reform risks, and competitive pressures, threatening future earnings stability and growth. Rising healthcare costs, increased utilization, and tech-driven competition could compress margins and undermine long-term profitability if operational efficiencies are not achieved.
View narrative
US$224.00
FV
22.7% overvalued
intrinsic discount
2.55%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
28 days ago
author updated this narrative
Humana
AN
AnalystConsensusTarget
Consensus Narrative from 22 Analysts
AI, In-Home Visits, Medicaid And CenterWell Will Improve Care Delivery
Key Takeaways Enhanced AI use improves customer interactions and operational efficiency, potentially benefiting net margins and reducing costs. Strategic acquisitions and focus on clinical excellence boost growth in primary care, improve quality outcomes, and support revenue increase.
View narrative
US$290.18
FV
5.3% undervalued
intrinsic discount
6.79%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
55
users have followed this narrative
7 days ago
author updated this narrative
Humana
AN
AnalystHighTarget
Consensus Narrative from 22 Analysts
Aging Population And Tech Will Shape Long-Term Medicare Care
Key Takeaways Growth in Medicare Advantage and CenterWell platforms, driven by demographic trends and care initiatives, positions Humana for sustained revenue and earnings improvement. Investments in advanced technology and value-based care enhance operational efficiency, margin expansion, and more stable, predictable profitability over time.
View narrative
US$348.00
FV
21.0% undervalued
intrinsic discount
9.35%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
21 days ago
author updated this narrative
Your Valuation for
HUM
HUM
Humana
Your Fair Value
US$
Current Price
US$274.94
0.4% overvalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
0
169b
2015
2018
2021
2024
2025
2027
2030
Revenue US$169.3b
Earnings US$2.2b
Advanced
Set Fair Value